Sarepta Therapeutics, Inc.
SRPT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000873303
No open-market purchases or sales by Sarepta Therapeutics, Inc. insiders were filed in the last 90 days; 323 institutions reported holding it in 13F filings for Q2 2026, worth $1.93B in total; no superinvestor holds it.
Superinvestors holding SRPT, Q2 2026
No superinvestor reported holding SRPT in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SRPT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2025
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q4 2024
1 superinvestor holding at quarter end
- Added
- Soros Fund Management (+11.8%)
Q3 2024
1 superinvestor holding at quarter end
Q2 2024
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q1 2024
1 superinvestor holding at quarter end
Q2 2023
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q1 2023
1 superinvestor holding at quarter end
Q4 2022
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q3 2022
1 superinvestor holding at quarter end
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−72.9%)